AbbVie (ABBV) Exchange Rate Effect (2013 - 2026)
AbbVie (ABBV) posted quarterly Exchange Rate Effect of -$12.0 million for Q1 2026, down 233.33% year-over-year from $9.0 million in Q1 2025, and down 209.09% quarter-over-quarter from $11.0 million in Q4 2025.
AbbVie (ABBV) Exchange Rate Effect (2013 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Exchange Rate Effect for 14 consecutive years, with -$12.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 233.33% year-over-year to -$12.0 million; the TTM figure through Mar 2026 stood at $21.0 million (up 155.26% YoY), while the FY2025 annual figure was $42.0 million, up 164.62% from the prior year.
- Exchange Rate Effect declined to -$12.0 million in Q1 2026 per ABBV's latest filing, from $11.0 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $30.0 million in Q2 2025 and bottomed at -$59.0 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$5.4 million across 5 years, with a median of -$8.0 million in 2025.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect slumped 325.0% — and 2025, when it surged 433.33%.
- AbbVie's Exchange Rate Effect stood at $23.0 million in 2022, then changed by 0.0% to $23.0 million in 2023, then slumped by 300.0% to -$46.0 million in 2024, then surged by 123.91% to $11.0 million in 2025, then sank by 209.09% to -$12.0 million in 2026.
- Business Quant data shows ABBV's Exchange Rate Effect at -$12.0 million in Q1 2026, $11.0 million in Q4 2025, and -$8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.75 Bn | 633.00 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 469.96 Bn | 463.39 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 376.93 Bn | 369.79 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 303.25 Bn | 295.56 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Astrazeneca | 257.53 Bn | 252.63 Bn | 12.86 Bn | 9.00 Mn |
| 6 | Amgen | 236.22 Bn | 222.23 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.19 Bn | 179.01 Bn | 6.22 Bn | -19.00 Mn |
| 8 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -4.00 Mn |
| 9 | Gsk | 106.27 Bn | 102.10 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.00 Bn | 47.62 Bn | 10.79 Bn | 11.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.00 Mn |
| Jun 30, 2026 | -7.00 Mn |
| Mar 31, 2026 | -12.00 Mn |
| Mar 31, 2026 | -12.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | -8.00 Mn |
| Sep 30, 2025 | -8.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | -46.00 Mn |
| Dec 31, 2024 | -46.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Mar 31, 2024 | -18.00 Mn |
| Mar 31, 2024 | -18.00 Mn |